SmPC- Sorafenib 200 mg film-coated tablets: Change history
View Summary of Product Characteristics (SmPC- Sorafenib 200 mg film-coated tablets)
Last updated on this site: 04 Mar 2025
To update sections 4.1, 4.2, 4.4, 4.8, and 5.1 of the SmPC to bring in line with the reference product Nexavar 200 mg film coated tablets (MAH: Bayer AG, Germany, EU procedure number: EMEA/H/C/000690). Consequentially, the PIL is also being updated.
SmPC sections updated: 4.1, 4.2, 4.4, 4.8, 5.1 & 10.
View Summary of Product Characteristics (SmPC- Sorafenib 200 mg film-coated tablets)
Last updated on this site: 04 Mar 2025
To update sections 4.1, 4.2, 4.4, 4.8, and 5.1 of the SmPC to bring in line with the reference product Nexavar 200 mg film coated tablets (MAH: Bayer AG, Germany, EU procedure number: EMEA/H/C/000690). Consequentially, the PIL is also being updated.
SmPC sections updated: 4.1, 4.2, 4.4, 4.8, 5.1 & 10.
-
Changes: (Updated: 04 Mar 2025)
To update sections 4.1, 4.2, 4.4, 4.8, and 5.1 of the SmPC to bring in line with the reference product Nexavar 200 mg film coated tablets (MAH: Bayer AG, Germany, EU procedure number: EMEA/H/C/000690). Consequentially, the PIL is also being updated.
SmPC sections updated: 4.1, 4.2, 4.4, 4.8, 5.1 & 10.
-
Changes: (Updated: 05 Jul 2023)
New SmPC for new product